CCN2 (Cyr61) stimulates the growth of breast and gastric adenocarcinomas [18,19], whereas its expression is downregulated in non-small cell lung cancer, in which CCN2 suppressed the growth of NSCLC cells by triggering a signal transduction pathway through β-catenin [20,21]. Here, CCN1 is linked to non-small cell lung carcinoma.